These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7889373)

  • 1. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF).
    Lee Y; Schulkin J; Davis M
    Brain Res; 1994 Dec; 666(1):93-8. PubMed ID: 7889373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine induced sensitization in acoustic startle: lack of blockade by adrenalectomy and alpha-helical CRF9-41.
    Chen DY; Liang KC
    Chin J Physiol; 2002 Jun; 45(2):75-87. PubMed ID: 12817721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.
    Pelton GH; Lee Y; Davis M
    Brain Res; 1997 Dec; 778(2):381-7. PubMed ID: 9459555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
    Liang KC; Melia KR; Campeau S; Falls WA; Miserendino MJ; Davis M
    J Neurosci; 1992 Jun; 12(6):2313-20. PubMed ID: 1607942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.
    Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M
    J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
    Swerdlow NR; Britton KT; Koob GF
    Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH
    Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli.
    Feldman S; Saphier D; Weidenfeld J
    Brain Res; 1992 Apr; 578(1-2):251-5. PubMed ID: 1324761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.
    Conti LH; Murry JD; Ruiz MA; Printz MP
    Psychopharmacology (Berl); 2002 May; 161(3):296-303. PubMed ID: 12021833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y; Davis M
    J Neurosci; 1997 Aug; 17(16):6434-46. PubMed ID: 9236251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.
    Swerdlow NR; Geyer MA; Vale WW; Koob GF
    Psychopharmacology (Berl); 1986; 88(2):147-52. PubMed ID: 3081925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats.
    Conti LH
    Eur J Pharmacol; 2005 Jan; 507(1-3):125-34. PubMed ID: 15659302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone.
    Toufexis DJ; Davis C; Hammond A; Davis M
    J Neurosci; 2004 Nov; 24(45):10280-7. PubMed ID: 15537900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cold in adrenalectomized, corticosterone (B)-treated rats: facilitated corticotropin responses to acute restraint emerge as B increases.
    Akana SF; Dallman MF
    Endocrinology; 1997 Aug; 138(8):3249-58. PubMed ID: 9231775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
    Schulz DW; Mansbach RS; Sprouse J; Braselton JP; Collins J; Corman M; Dunaiskis A; Faraci S; Schmidt AW; Seeger T; Seymour P; Tingley FD; Winston EN; Chen YL; Heym J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10477-82. PubMed ID: 8816826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.
    Keen-Rhinehart E; Michopoulos V; Toufexis DJ; Martin EI; Nair H; Ressler KJ; Davis M; Owens MJ; Nemeroff CB; Wilson ME
    Mol Psychiatry; 2009 Jan; 14(1):37-50. PubMed ID: 18698320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on hypothalamo-pituitary corticoliberin system. IV. Quantitative changes in ACTH-immunoreactive anterior pituitary cells evoked by long-term intraventricular CRF administration and adrenalectomy.
    Miśkowiak B; Stachowiak A; Zabel M; Malendowicz LK
    Exp Clin Endocrinol; 1987 Sep; 90(2):178-84. PubMed ID: 2828081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
    Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.